Pharmafile Logo
Pharmafocus logo
Advanced Search

Medical Communications

Showing 15 posts of 6408 posts found.

david-travis-avvzjc0ynbq-unsplash

FDA approves Apellis’ geographic atrophy treatment

February 20, 2023 Medical Communications

Apellis’ Syfovre (pegcetacoplan injection) is indicated for patients with geographic atrophy (GA) with or without subfoveal involvement, and has received …
News

Medtronic’s extravascular defibrillator receives CE mark

February 20, 2023 Medical Communications

Medtronic has received CE mark for its extravascular defibrillator. The Aurora EV-ICD™ MRI SureScan™ and Epsila EV™ MRI SureScan™ defibrillation …
News

Pfizer’s Lyme disease vaccine study cut due to protocol violations

February 20, 2023 Medical Communications

Valneva and Pfizer have seen their Lyme disease vaccine study cut down after some clinical trial sites were revealed to …
News

Sun Pharma recalls at least 34,000 bottles of generic drug

February 13, 2023 Medical Communications

Mumbai-based pharma company, Sun Pharma, has announced that it is recalling over 34,000 bottles of a generic drug, Diltiazem Hydrochloride, …
News

AstraZeneca moves manufacturing to Ireland due to Britain’s tax regime

February 10, 2023 Medical Communications

Big pharma giant, AstraZeneca, has announced that its plans to open a new facility in northwest England have now changed, …
News

FDA grants full approval to GSK for mismatch repair-deficient endometrial cancer treatment

February 10, 2023 Medical Communications

GSK announced that its treatment for recurrent or advanced mismatch repair-deficient (dMMR) endometrial cancer has been granted full approval by …
News

Stand Up To Cancer announces four teams dedicated to increasing diversity in clinical trials

February 9, 2023 Medical Communications

Stand Up To Cancer (SU2C) has announced four teams that will focus on increasing diversity in early phase cancer clinical …
News

FDA grants RMAT designation for Mesoblast’s chronic low back pain treatment

February 9, 2023 Medical Communications

Mesoblast Ltd, an Australian regenerative medicine company leading in allogeneic cellular medicines for inflammatory diseases, announced that its treatment for …
News

Scottish biotech aims to cure common cold

February 8, 2023 Medical Communications

Scottish biotech company ScotBio has announced that it has seen “promising initial results” from its attempts to extract a cure …
News

AstraZeneca’s Forxiga approved in EU for chronic heart failure

February 7, 2023 Medical Communications

AstraZeneca has announced that its drug, Forxiga, has been approved in the EU for the treatment of symptomatic chronic heart …
News

Genentech shares positive results from global phase 3 trials for crovalimab in PNH

February 7, 2023 Medical Communications

Following the global COMMODORE 2 study, Genentech has announced positive data for crovalimab in treating patients with paroxysmal nocturnal haemoglobinuria …
News

Boston Scientific fined $42m over patent infringement

February 6, 2023 Medical Communications

A five-year legal battle between Boston Scientific and TissueGen has culminated in a $42m fine, which Boston Scientific must pay …
News

Drug-resistant bacteria found in eye drops has infected 55 people in 12 states

February 3, 2023 Medical Communications

A strongly drug-resistant bacteria has been found in multiple brands of artificial tears eyedrops; the most commonly reported was EzriCare …
News

DrugBAN AI expected to reduce costs and speed up drug discovery

February 3, 2023 Medical Communications

In a collaboration between Sheffield University and pharma giant, AstraZeneca, a new AI has been developed which could help deliver …
News

Genoscience Pharma received Orphan Drug Designation for hepatocellular carcinoma drug

February 3, 2023 Medical Communications

French clinical-stage biotech company Genoscience has received FDA Orphan Drug Designation (ODD) for its lead candidate ezurpimtrostat. OOD qualifies the …
News
The Gateway to Local Adoption Series

Latest content

Rhythm AI’s STAR Apollo system receives FDA clearance for atrial fibrillation

February 12, 2026

iOrganBio appoints Karol Jarzabek as Chief Operating Officer

February 12, 2026

Ensera Design expands UK leadership team with new senior appointments

February 11, 2026

Infinitopes announces $15.4m in additional seed funding to advance cancer vaccine

February 11, 2026

Angelini Pharma appoints Roberto Scrivo as Chief of External Affairs, Communication and Sustainability Officer

February 10, 2026